Skin and Soft Tissue Infections
📧 Sign up to get email alerts when something new happens for Skin and Soft Tissue Infections.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-03-15FDA Approved: LINEZOLID — Original Application (Hp Halden Pharma AS)
FDA approved a generic version of the antibiotic linezolid (Hp Halden Pharma AS) under an original ANDA submission.
-
FDA approval · 2016-01-21FDA Approved: CLEOCIN HYDROCHLORIDE — Supplemental Application (Pharmacia & Upjohn Company LLC)
The FDA approved a supplemental application for CLEOCIN HYDROCHLORIDE (clindamycin hydrochloride) filed by Pharmacia & Upjohn Company LLC.
-
FDA approval · 2015-12-21FDA Approved: LINEZOLID — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings, Inc.'s generic LINEZOLID (linezolid) under an original application (ANDA), enabling market entry of a g…
-
FDA approval · 2015-09-28FDA Approved: CLARITHROMYCIN — Original Application (Solaris Pharma Corporation)
FDA approved an Original Application (ANDA) for Clarithromycin from Solaris Pharma Corporation, establishing a generic version of clarithrom…
-
FDA approval · 2015-07-16FDA Approved: LINEZOLID — Original Application (Sandoz Inc)
FDA approved Sandoz Inc.'s Original Application (ANDA) for LINEZOLID, enabling a generic linezolid product to be marketed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-06-03FDA Approved: LINEZOLID — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approves Hikma Pharmaceuticals USA Inc.'s generic LINEZOLID (linezolid) under an Original Abbreviated New Drug Application.
-
FDA label_change · 2014-09-22FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Northstar RxLLC)
The FDA approved a supplemental application for amoxicillin and clavulanate potassium filed by Northstar RxLLC, resulting in a label update …
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections [Phase 4]
A Phase 4 trial evaluated daptomycin for emergency department treatment of complicated skin and soft tissue infections. Results were posted …
-
FDA approval · 2013-05-03FDA Approved: LINEZOLID — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for LINEZOLID submitted by Mylan Pharmaceuticals Inc. The action reflects an approved modification t…
-
CLINICAL_TRIALS trial_result · 2012-11-22Clinical Trial Update: AUGMENTIN 1gm In Skin And Soft Tissue Infection [Phase 4]
Phase 4 clinical trial update showing completion of a study evaluating Augmentin 1 g for skin and soft tissue infections.
-
CLINICAL_TRIALS trial_result · 2012-11-16Clinical Trial Update: Avelox in Complicated Skin and Skin Structure Infections
A Bayer-sponsored trial evaluating moxifloxacin (Avelox) for complicated skin and skin structure infections has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections [Phase 4]
Phase 4 clinical trial update comparing tigecycline to ampicillin-sulbactam or amoxicillin-clavulanate for skin and soft tissue infections, …
-
CLINICAL_TRIALS trial_result · 2012-08-08Clinical Trial Update: Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA) [Phase 4]
Pfizer-sponsored Phase 4 trial update reporting results for skin and soft tissue infections with suspected or proven MRSA; results were post…
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections [Phase 3]
Phase 3 trial evaluating ceftobiprole for resistant Staphylococcus aureus skin and soft tissue infections has completed.
-
FDA approval · 2012-07-25FDA Approved: CLARITHROMYCIN — Original Application (Rising Pharma Holdings, Inc.)
FDA approved a generic clarithromycin product under an original ANDA from Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS withdrawal · 2012-06-07Clinical Trial Update: Study Evaluating Tigecycline Versus Clindamycin Or Vancomycin On Complicated Skin And Skin Structure Infections Including Those Due To Methicillin-Resistant Staphylococcus Aureus (MRSA) In Pediatric Subjects [Phase 3]
A Phase 3 trial evaluating tigecycline versus clindamycin or vancomycin for complicated skin and skin-structure infections in pediatric pati…
-
CLINICAL_TRIALS trial_result · 2012-02-01Clinical Trial Update: Post-Authorization Study Evaluating Safety Of Tigecycline
Pfizer completed a post-authorization safety study evaluating tigecycline, with results posted in February 2012. The safety data cover patie…
-
CLINICAL_TRIALS trial_result · 2011-07-08Clinical Trial Update: Evaluating the Use of Large-dose, Extended Interval Vancomycin Intravenous Administration for Skin and Soft Tissue Infections [NA]
A completed clinical trial evaluating high-dose, extended-interval intravenous vancomycin for skin and soft tissue infections, with results …
-
FDA approval · 2011-06-30FDA Approved: NAFCILLIN — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original application for Nafcillin sodium (NAFCILLIN SODIUM) as a generic injectable antibiotic from Fresenius Kabi USA, LL…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Uncomplicated Infections of the Skin and the Supportive Layers Beneath the Skin [Phase 3]
A Phase 3 randomized study comparing oral levofloxacin to oral ciprofloxacin in adults with uncomplicated skin and soft tissue infections ha…
-
FDA approval · 2011-05-04FDA Approved: CEPHALEXIN — Supplemental Application (AvKARE)
FDA approved a supplemental application for Cephalexin from AvKARE under ANDA 062713, authorizing continued manufacture and marketing of a C…
-
FDA approval · 2011-04-20FDA Approved: NAFCILLIN — Original Application (Athenex Pharmaceutical Division, LLC.)
FDA approves the original application for Nafcillin (nafcillin sodium) as a generic antibiotic from Athenex Pharmaceutical Division, LLC.
-
FDA approval · 2011-02-22FDA Approved: CEPHALEXIN — Supplemental Application (AVKARE)
The FDA approved a supplemental application for Cephalexin from AvKare.
-
CLINICAL_TRIALS trial_result · 2011-01-05Clinical Trial Update: What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center?
This completed clinical trial reports the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in skin and soft tissue infection…
-
FDA approval · 2010-12-20FDA Approved: CEPHALEXIN — Original Application (AvPAK)
FDA approved the original application for Cephalexin (generic) from AvPAK under ANDA090836.